Analysis of 16S rrna
Ended Purchase Order Awarded Last action
- Contract number
- 75N91018P00659
- Awardee
-
Resphera Biosciences LLC UEI KN8XS8DJHMF1
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $14,500
Award facts
- Contract value 100% obligated
- $14,500.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute awarded a purchase order to Resphera Biosciences LLC for $14,500 on August 30, 2018, for analysis of 16S rRNA. Work is performed in Bethesda, Maryland, with completion targeted for December 29, 2018. The order carries firm fixed price terms.
Quick answers
Who was awarded contract 75N91018P00659?
75N91018P00659 was awarded to Resphera Biosciences LLC by National Cancer Institute (National Institutes of Health) on August 30, 2018.
How much is contract 75N91018P00659 worth?
The government has obligated $14,500 on 75N91018P00659.
Was contract 75N91018P00659 competed?
The extent of competition for 75N91018P00659 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award